Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Jan 27, 2022; 14(1): 46-55
Published online Jan 27, 2022. doi: 10.4240/wjgs.v14.i1.46
Published online Jan 27, 2022. doi: 10.4240/wjgs.v14.i1.46
Table 1 Clinicopathologic characteristics of the study population
| All (n = 122) | |
| Sex | |
| Male/female | 96 (78.7%)/26 (21.3%) |
| Age, median (min, max) | 68 (35-87) |
| Histology | |
| Adenocarcinoma/squamous cell carcinoma | 95 (77.9%)/27 (22.1%) |
| Neoadjuvant | 32 (26.2%) |
| Adjuvant | 27 (22.1%) |
| Approach | |
| Transthoracic/transhiatal | 47 (38.5%)/75 (61.5%) |
| Reconstruction site | |
| Cervical/Intrathoracic | 22 (18.0%)/100 (82.0%) |
| Subtotal esophagectomy | 41 (33.6%) |
| Total gastrectomy | 37 (30.3%) |
| Splenectomy | 16 (13.1%) |
| Operating time (min); median (range) | 299 (114-775) |
| Amount of bleeding (mL); median (range) | 180 (10-4858) |
| Tumor epicenter | |
| Esophageal side/gastric side | 52 (42.6%)/70 (57.4%) |
| Distance from the EGJ to the tumor center (mm) | 1.5 (-201-20) |
| Esophageal invasion (mm) | 11.5 (0-55) |
| Tumor diameter (mm) | 32 (6-100) |
| Pathologic stage of esophageal cancer | |
| Stage I/stage II/stage III/stage IV | 44 (36.1%)/24 (19.7%)/38 (31.2%)/16 (13.1%) |
| Residual cancer | |
| R0/R1 | 111 (91.0%)/11 (9.0%) |
- Citation: Takeuchi M, Kawakubo H, Matsuda S, Mayanagi S, Irino T, Okui J, Fukuda K, Nakamura R, Wada N, Takeuchi H, Kitagawa Y. Association of anastomotic leakage with long-term oncologic outcomes of patients with esophagogastric junction cancer. World J Gastrointest Surg 2022; 14(1): 46-55
- URL: https://www.wjgnet.com/1948-9366/full/v14/i1/46.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i1.46